The Epidemiology of Rickettsial Infections in South India: Cohort Study
The Epidemiology Of Scrub Typhus And Rickettsial Infections In A Highly Endemic Rural Setting In South India: Population-Based Cohort Study
1 other identifier
observational
32,566
1 country
1
Brief Summary
There is enough evidence to suggest that scrub typhus and spotted fever group rickettsioses are common causes of febrile illness in India. Serological evidence also exists for murine typhus, but is rarely tested for. Incidence, risk factors, clinical features and molecular epidemiology of these three infections are poorly understood. Delays in disease recognition and treatment may cause thousands of preventable deaths across India. The objectives of the research are to determine the incidence and risk factors of scrub typhus, spotted fever and murine typhus by severity, to determine clinical features of these neglected and often unrecognized infections. Further to study the effect of previous infection on incidence and severity of subsequent infections. Finally to study the association between vector parameters and scrub typhus risk. Enrolled will be 30,000 individuals who will be followed up for the development of fever using active and passive surveillance. Active surveillance will include household screening every 3-6 weeks. Fever cases occuring in the past two months will be tested for Scrub typhus, murine typhus and spotted fever IgG/IgM. 4000 individuals will be followed up by annual serological testing to identify asymptomatic infections. Participants notifying the study team with ongoing fever will undergo blood testing for acute diagnosis of rickettsial infection (IgM, PCR). In addition, we will enroll fever cases at study clinics who are not part of the main cohort. The research includes spatial and socio-economic risk factor analysis. Rodents carrying mite larvae will be trapped to compare the intensity of mite infestation between areas of high and low risk for human scrub typhus. The data on incidence, burden of disease and environmental determinants of scrub typhus, spotted fever and murine typhus will be used for health care planning and information campaigns for the public and medical professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 7, 2020
CompletedFirst Posted
Study publicly available on registry
August 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedOctober 5, 2023
October 1, 2023
2 years
August 7, 2020
October 4, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence of scrub typhus
clinically apparent infection
2 years
Incidence of spotted fever
clinically apparent infection
2 years
Incidence of murine typhus
clinically apparent infection
2 years
Secondary Outcomes (6)
Incidence of serological infection (scrub typhus)
2 years
Incidence of serological infection (spotted fever)
2 years
Incidence of serological infection (murine typhus)
2 years
Incidence of complicated infection (scrub typhus)
2 years
Incidence of complicated infection (spotted fever)
2 years
- +1 more secondary outcomes
Study Arms (3)
General population
Whole population of scrub typhus endemic villages
hospital case population
cases recruited at study clinics who are not enrolled in general population cohort
Serological cohort
random subset of 4000 participants above the age of 10 drawn from general population cohort
Interventions
No specific exposure is explored.
Eligibility Criteria
General population cohort: all residents in scrub typhus endemic villages Serological cohort: random sample of 4000 individuals older than 10 years present at the time of the initial baseline survey visit hospital case cohort: cases of all ages attending study clinics for undifferentiated fever of at least 5 days duration
You may qualify if:
- General population cohort: residing in study villages
- serological cohort: aged 10 years or older
- Hospital cohort: all ages
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- London School of Hygiene and Tropical Medicinelead
- Medical Research Councilcollaborator
- Christian Medical College, Vellore, Indiacollaborator
- Mahidol Oxford Tropical Medicine Research Unitcollaborator
- Australian Rickettsial Reference Laboratorycollaborator
Study Sites (1)
Christian Medical College
Vellore, Tamil Nadu, 632004, India
Related Publications (1)
Devamani C, Alexander N, Chandramohan D, Stenos J, Cameron M, Abhilash KPP, Mangtani P, Blacksell S, Vu HTT, Rose W, Schmidt WP. Incidence of Scrub Typhus in Rural South India. N Engl J Med. 2025 Mar 13;392(11):1089-1099. doi: 10.1056/NEJMoa2408645.
PMID: 40073309DERIVED
Biospecimen
Blood samples from human participants: serum for serological testing, buffy coat for rickettsia PCR Eschar and skin biopsies for rickettsia PCR Arthropod vector samples: PCR for rickettsia Rodent tissue samples: PCR for rickettsia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wolf-Peter Schmidt, PhD
London School of Hygiene and Tropical Medicine
- STUDY CHAIR
Daniel Chandramohan, PhD
London School of Hygiene and Tropical Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2020
First Posted
August 10, 2020
Study Start
August 1, 2020
Primary Completion
August 5, 2022
Study Completion
July 31, 2023
Last Updated
October 5, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- from 12/2022 indefinitely
- Access Criteria
- on request
de-identified case data will be made available at LSHTMs data repository